Plea In Delhi High Court Seeks Remdesivir Sale In Domestic Market

The remaining companies were involved in manufacturing the drug for export, petitioner Dincur Bajaj said, adding that since the export of Remdesivir has been banned by the Centre, the companies which were producing it for export be permitted to manufacture and sell it in the domestic market.

The Delhi High Court Monday asked the Centre and various pharma majors to respond to a PIL seeking that all drug firms making Remdesivir, used in COVID-19 treatment, be allowed to sell it in the domestic market. A bench of Chief Justice D N Patel and Justice Jasmeet Singh issued notice to the Health Ministry, Central Drugs Standard Control Organisation, Director General of Foreign Trade, and various pharma companies, like Cipla, Zydus and Cadila, seeking their stand on the plea which claims only a handful of such firms are allowed to sell the medicine in the domestic market. The remaining companies were involved in manufacturing the drug for export, petitioner Dincur Bajaj said, adding that since the export of Remdesivir has been banned by the Centre, the companies which were producing it for export be permitted to manufacture and sell it in the domestic market.